The 50 % human infectious dose was calculated to be 3.3 reverse transcription polymerase chain reaction units ( approximately 1320 genomic equivalents [ gEq ] ) for secretor-positive blood group O or A persons and 7.0 ( approximately 2800 gEq ) for all secretor-positive persons .